Finnish study shows medical cannabis users report broader benefits—mood, sleep, daily functioning—beyond chronic-pain relief, versus opioids; research needed.
Discover why clinician education became a key barrier to UK medical cannabis access—and how experts are closing the knowledge gap to improve patient care.
New 2021 treatment data reveal high cannabis-related admissions in many states without adult-use sales, but data caveats keep verdicts on legalization elusive.
New evidence shows cannabis is not a proven treatment for depression or most mental health conditions—learn what the data really say and safety concerns.
A small observational study links regular cannabis use to higher emotional understanding on an empathy measure, with brain-connectivity hints but no proof.
Could CBD curb Alzheimer's inflammation? A 2023 mouse study hints memory benefits. However human efficacy dosing and safety remain unproven.
NIH funds a cannabis and cannabinoid research center to clear regulatory hurdles, standardize methods, and boost support for researchers
Discover how cannabis testing labs navigate evolving state rules, ISO/IEC 17025 accreditation, and shifting federal oversight to stay compliant.
Could cannabis legalization reshape young adults' habits? A LA study explores shifts in alcohol, smoking, and edibles after adult-use policy took effect.
California's 2018 cannabis testing shift exposed labeling flaws and contamination risks, underscoring the need for reliable labs and accurate packaging.